Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.47 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MAPT | P10636 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.47 |
| ▸ | CES1 | P23141 | 1/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16858613 | 1.00 | CES2 (0.53) | CES2MEN1KMT2AKDM4EDUSP3 | |
| SCHEMBL16584512 | 1.00 | CES2 (0.53) | CES2MEN1KMT2AKDM4EDUSP3 | |
| SCHEMBL14777584 | 1.00 | CES2 (0.53) | CES2MEN1KMT2AKDM4EDUSP3 | |
| SCHEMBL235095 | 1.00 | CES2 (0.53) | CES2MEN1KMT2AKDM4EDUSP3 | |
| SCHEMBL18339530 | 1.00 | CES2 (0.53) | CES2MEN1KMT2AKDM4EDUSP3 | |
| SCHEMBL360532 | 1.00 | CES2 (0.53) | CES2MEN1KMT2AKDM4EDUSP3 | |
| SCHEMBL19357245 | 1.00 | CES2 (0.53) | CES2MEN1KMT2AKDM4EDUSP3 | |
| SCHEMBL9056653 | 1.00 | CES2 (0.53) | CES2MEN1KMT2AKDM4EDUSP3 | |
| SCHEMBL378473 | 1.00 | CES2 (0.53) | CES2MEN1KMT2AKDM4EDUSP3 | |
| SCHEMBL976649 | 1.00 | CES2 (0.53) | CES2MEN1KMT2AKDM4EDUSP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 839 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3849511-B1 | METHODS FOR THE PREPARATION OF A PHARMACEUTICAL-VESICLE FORMULATION AND ASSOCIATED PRODUCTS AND USES | SECR DEFENCE (GB) | 2025-12-24 | — | — | EP | claimed |
| EP-3808729-B1 | METHOD FOR PRODUCING 1-PALMITOYL-2-LINOLEOYL-3-ACETYL GLYCEROL | ENZYCHEM LIFESCIENCES CORP (KR) | 2025-12-10 | — | — | EP | claimed |
| CN-119816897-A | Multiple study assessment | 普罗科技有限公司 | 2025-04-11 | — | — | CN | claimed |
| CN-112437662-B | Novel compounds isolated from velvet antler and pharmaceutical uses thereof | FNG研究有限公司 | 2024-09-06 | — | — | CN | claimed |
| US-12050228-B2 | Automated sample quality assessment | METABOLON, INC. (US) | 2024-07-30 | — | — | US | claimed |
| US-11923082-B2 | Method and system for rapid prediction offast blood glucose level in pregnant subjects | HANGZHOU CALIBRA DIAGNOSTICS CO., LTD. (CN) | 2024-03-05 | — | — | US | claimed |
| WO-2023240046-A2 | MULTI-OMICS ASSESSMENT | PrognomIQ, Inc. (US) | 2023-12-14 | — | — | WO | claimed |
| US-20230307120-A1 | METHOD AND SYSTEM FOR RAPID PREDICTION OFFAST BLOOD GLUCOSE LEVEL IN PREGNANT SUBJECTS | HANGZHOU CALIBRA DIAGNOSTICS CO., LTD. (CN) | 2023-09-28 | — | — | US | claimed |
| CN-116519812-A | Application of biomarker in preparation of gestational diabetes diagnostic reagent | 杭州凯莱谱精准医疗检测技术有限公司 | 2023-08-01 | — | — | CN | claimed |
| EP-3554255-B1 | COMPOSITIONS AND METHODS THAT MODULATE CHOLESTEROL IN A COMPANION ANIMAL | NESTLE SA (CH) | 2023-07-19 | — | — | EP | claimed |
| EP-1003567-A1 | TEMPERATURE-CONTROLLED pH-DEPENDANT FORMATION OF IONIC POLYSACCHARIDE GELS | Bio-Syntech Ltd. (CA) | 2000-05-31 | — | — | EP | claimed |
| EP-0722341-B1 | Non-ionic surfarctant vesicles comprising antigens | UNIV STRATHCLYDE (GB) | 2000-01-12 | — | — | EP | claimed |
| US-5876721-A | VESICLES COMPRISING AT LEAST ONE NON-IONIC SURFACTANT; CHOLESTEROL DERIVATIVES IN WHICH THE C23 CARBON OF SIDE CHAINE HAS A CARBOXYLIC ACID, BILE ACIDS OR ACYLOXALATED AMINO ACIDS | PROTEUS MOLECULAR DESIGN LIMITED (GB) | 1999-03-02 | — | — | US | claimed |
| WO-1999007416-A1 | TEMPERATURE-CONTROLLED pH-DEPENDANT FORMATION OF IONIC POLYSACCHARIDE GELS | BIO-SYNTECH LTD. (CA) | 1999-02-18 | — | — | WO | claimed |
| EP-0861074-A1 | NON-IONIC SURFACTANT VESICLES AS THERAPEUTIC AGENT | PROTEUS MOLECULAR DESIGN LIMITED (GB) | 1998-09-02 | — | — | EP | claimed |
| US-5679355-A | ENTRAPPED ANTIGENS ACT AS POTENT IMMUNOLOGICAL ADJUVANTS; GLYCEROL ESTERS | PROTEUS MOLECULAR DESIGN LIMITED (GB) | 1997-10-21 | — | — | US | claimed |
| EP-0634937-B1 | VACCINES CONTAINING NON-IONIC SURFACTANT VESICLES | PROTEUS MOLECULAR DESIGN (GB) | 1997-09-17 | — | — | EP | claimed |
| US-5607970-A | GLYCEROL MONOSTEARATE OR PALMITATE | KABUSHIKI KAISYA ADVANCE (JP) | 1997-03-04 | — | — | US | claimed |
| WO-1997004768-A1 | NON-IONIC SURFACTANT VESICLES AS THERAPEUTIC AGENT | PROTEUS MOLECULAR DESIGN LIMITED (GB) | 1997-02-13 | — | — | WO | claimed |
| US-5525472-A | MIXING NEUTRALIZED FATTY ACIDS, TRIGLYCERIDES OR MONOGLYCERIDES INTO ESCHERICHIA CULTURES, THEN CELL LYSIS IN PRESENCE OF MAGNESIUM IONS AND TREATMENT OF INSOLUBLE RECOVERED MATERIAL WITH NONIONIC DETERGENTS | BIO-TECHNOLOGY GENERAL CORP. (US) | 1996-06-11 | — | — | US | claimed |